Pharmaceutical

Novo Nordisk invests $4.1bn in manufacturing facility in NC

Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.

Jun 26, 2024 - 04:00
Novo Nordisk invests $4.1bn in manufacturing facility in NC
Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.
Read the original article

Tags:

Previous Article

GSK’s Omjjara gains approval in Japan for myelofibrosis treatment

Next Article

Disappointing Phase 3 Trial Results Cause Merck to Shelve Head and Neck Cancer Drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

UK MHRA approves Advanz Pharma antibiotic for complex infections

UK MHRA approves Advanz Pharma antibiotic for complex i...

Apr 7, 2024

Rats have an imagination, too, researchers show with brain implants

Rats have an imagination, too, researchers show with br...

Nov 3, 2023

Dizal receives approval in China for NSCLC therapy

Dizal receives approval in China for NSCLC therapy

Aug 24, 2023